Log In
BCIQ
Print this Print this
 

TRX518

  Manage Alerts
Collapse Summary General Information
Company Leap Therapeutics Inc.
DescriptionHumanized IgG1 mAb against glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR; TNFRSF18)
Molecular Target Glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) (TNFRSF18)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat stage III or IV malignant melanoma or other solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/29/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today